Genopharm specializes in biopharmaceutical research and development, focusing on creating innovative treatments for human diseases. They are currently developing cancer-immune pharmaceuticals utilizing antibody cytokine fusion protein technology to offer personalized therapy for breast and gastric cancer.

Vision and Mission: Genopharm’s vision is to be at the forefront of personalized medicine, transforming cancer treatment through targeted therapies. Their mission is to develop and provide advanced, patient-specific pharmaceuticals that significantly improve treatment outcomes.

Noteworthy Points: The company has made significant strides in the biopharma sector with its cutting-edge research and has secured funding from notable investors like the TIPS Program.